Chloroquine resistance in Plasmodium falciparum. 1961

M D YOUNG, and D V MOORE

UI MeSH Term Description Entries
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M D YOUNG, and D V MOORE
November 1987, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
M D YOUNG, and D V MOORE
January 1964, Revista brasileira de malariologia e doencas tropicais. Publicacoes avulsas,
M D YOUNG, and D V MOORE
June 2001, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy,
M D YOUNG, and D V MOORE
August 1987, Parasitology today (Personal ed.),
M D YOUNG, and D V MOORE
June 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
M D YOUNG, and D V MOORE
September 2002, Medicinal research reviews,
M D YOUNG, and D V MOORE
September 1983, The American journal of tropical medicine and hygiene,
M D YOUNG, and D V MOORE
November 1987, Science (New York, N.Y.),
Copied contents to your clipboard!